These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20012106)

  • 21. Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats.
    Koizumi S; Odashima M; Otaka M; Jin M; Linden J; Watanabe S; Ohnishi H
    J Gastroenterol; 2009; 44(5):419-25. PubMed ID: 19333545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cells do not contribute to nonsteroidal anti-inflammatory drug-induced gastric mucosal injury in rodents.
    Rioux KP; Wallace JL
    Aliment Pharmacol Ther; 1996 Apr; 10(2):173-80. PubMed ID: 8730246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation.
    Amano T; Ariga H; Kurematsu A; Yamato S; Morioka S; Masaka A; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2015 Sep; 27(9):1303-9. PubMed ID: 26303048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroprotective effect of L-carnitine on indomethacin-induced gastric mucosal injury in rats: a preliminary study.
    Erkin B; Dokmeci D; Altaner S; Turan FN
    Folia Med (Plovdiv); 2006; 48(3-4):86-9. PubMed ID: 17668703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggravation by paroxetine, a selective serotonin reuptake inhibitor, of antral lesions generated by nonsteroidal anti-inflammatory drugs in rats.
    Takeuchi K; Tanaka A; Nukui K; Kojo A; Gyenge M; Amagase K
    J Pharmacol Exp Ther; 2011 Sep; 338(3):850-9. PubMed ID: 21705613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
    Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
    J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles.
    Kii Y; Ito T
    J Cardiovasc Pharmacol; 1997 May; 29(5):670-5. PubMed ID: 9213211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric emptying after artificial ulceration in rats: differences due to the site of the ulcer and the effects of prokinetic drugs.
    Uchida M; Kobayashi O; Shimizu K
    J Smooth Muscle Res; 2017; 53(0):48-56. PubMed ID: 28652516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
    Toga T; Kohmura Y; Kawatsu R
    J Pharmacol Sci; 2007 Oct; 105(2):207-10. PubMed ID: 17928736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of 5-HT4 receptor agonist, mosapride citrate, on visceral hypersensitivity in a rat model.
    Lee JW; Sung KW; Lee OY; Lee SE; Sohn CI
    Dig Dis Sci; 2012 Jun; 57(6):1517-24. PubMed ID: 22427128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.
    Kii Y; Nakatsuji K; Nose I; Yabuuchi M; Mizuki Y; Ito T
    Pharmacol Toxicol; 2001 Aug; 89(2):96-103. PubMed ID: 11555327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition.
    Park JM; Han YM; Kangwan N; Lee SY; Jung MK; Kim EH; Hahm KB
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():80-92. PubMed ID: 25521739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid.
    Komoike Y; Takeeda M; Tanaka A; Kato S; Takeuchi K
    Dig Dis Sci; 2002 Jul; 47(7):1538-45. PubMed ID: 12141814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of esophageal acid infusion vs mosapride on distension-induced secondary peristalsis in humans.
    Lei WY; Hung JS; Yi CH; Liu TT; Wong MW; Chen CL
    Kaohsiung J Med Sci; 2019 May; 35(5):310-314. PubMed ID: 30897296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroprotective effect of Cochinchina momordica seed extract in nonsteroidal anti-inflammatory drug-induced acute gastric damage in a rat model.
    Lim JH; Kim JH; Kim N; Lee BH; Seo PJ; Kang JM; Jo SY; Park JH; Nam RH; Chang H; Kwon JW; Lee DH
    Gut Liver; 2014 Jan; 8(1):49-57. PubMed ID: 24516701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.
    Ruth M; Hamelin B; Röhss K; Lundell L
    Aliment Pharmacol Ther; 1998 Jan; 12(1):35-40. PubMed ID: 9692698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.